AC Immune Announces the Selection of Tau Small Molecules for Clinical Development in Alzheimer’s disease
pharmaceutical investing Denali Therapeutics Announces Reports Full Year 2017 Financial Results And Business Highlights
pharmaceutical investing Novartis and Pear Therapeutics to develop digital therapeutics for patients with schizophrenia and multiple sclerosis
ProMIS Neurosciences Lead Product Candidate for Alzheimer’s Disease Shows Potential for Improved Therapeutic Potency
American Uranium Reports Strong Early Infill Drilling Results at its 9.45Mlb Lo Herma ISR Uranium Project in Wyoming's Powder River Basin Ahead of Q3 Resource Upgrade
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
Nevada Sunrise Enters into Earn-in Option Agreement for the Fivemile Gold Project, Cortez Mining District, Nevada